Clinical Trials Logo

Electro-acupuncture clinical trials

View clinical trials related to Electro-acupuncture.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT05890508 Recruiting - Long Covid19 Clinical Trials

Electro-acupuncture for Long Covid Neuropsychiatric Symptoms

Start date: March 1, 2024
Phase: N/A
Study type: Interventional

In this study, a 16-week randomized, sham-controlled, double-blinded clinical trial will be conducted to to investigate the efficacy and safety of electro-acupuncture compared to sham acupuncture for treatment of long covid neuropsychiatric symptoms.

NCT ID: NCT05514067 Recruiting - Clinical trials for Coronary Artery Disease

Electroacupuncture for Heart Protection: Clinical Application in Patients Undergoing Cardiac Bypass Surgery

EA-CABG
Start date: July 9, 2020
Phase: N/A
Study type: Interventional

Coronary artery disease (CAD) is the leading cause of death and disability in Singapore and worldwide. Many patients with multi-vessel CAD require surgical revascularisation by coronary artery bypass graft (CABG) surgery, and are at risk of postsurgical complications such as peri-operative myocardial injury (PMI), left ventricular dysfunction, heart failure, and death. This risk is particularly important given that the aging population, and increased prevalence of co-morbidities (diabetes, hypertension, renal failure) and complexity of cardiac surgery, mean that higher risk patients are undergoing CABG surgery. As such, new treatment strategies are required to protect the heart during CABG surgery in order to improve health outcomes in patients with CAD. In this regard, a number of animal studies have demonstrated that electroacupuncture (EA) at cardiac-related acupoints can protect the heart against the detrimental effects of acute ischaemia/reperfusion injury (IRI). However, the mechanisms underlying the beneficial effect of EA, and whether EA can protect the heart against PMI in patients undergoing CABG surgery are not known. Therefore, in this research proposal, the investigators will investigate whether EA at cardiac-related acupoints can protect the heart against PMI during CABG surgery, and the investigators will elucidate the mechanisms underlying the cardioprotective effects of EA.

NCT ID: NCT03061396 Recruiting - Clinical trials for Chemotherapy-induced Nausea and Vomiting

The Comparative Study on the Efficacy and Safety of Single Acupoint and Matching Acupoints

Start date: February 17, 2017
Phase: N/A
Study type: Interventional

The purpose of this study is to clarify whether the matching acupoints are more effective than a single point by electro-acupuncture in the management of chemotherapy-induced nausea and vomiting.